Clinical Trial Update: Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS) [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial investigates isunakinra alone and in combination with pembrolizumab for metastatic colorectal cancer (MSS) and is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Isunakinra (isunakinra)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Buzzard Pharmaceuticals | Conditions: Colorectal Cancer Metastatic | Phase 2 | Status: RECRUITING